Skip to content
healthcare.dev

Tiagabine Hydrochloride

NDC 72205-085, Tiagabine Hydrochloride, tablet, from Novadoz Pharmaceuticals LLC.

Product NDC
72205-085
Status
Listed
Labeler
Novadoz Pharmaceuticals LLC
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA214816
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/72205-085 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TIAGABINE HYDROCHLORIDE4 mg/1

Pharmacologic classes

Anti-epileptic Agent [EPC]; Decreased Central Nervous System Disorganized Electrical Activity [PE]

Package NDCNDC-11Package
72205-085-307220500853030 TABLET in 1 BOTTLE (72205-085-30)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/7c034fe0-cdac-49e1-8e39-592846ea3bec
  • NADAC price for package 72205008530

    GET /v1/drugs/nadac/72205008530

Use it

Look up 72205-085 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/72205-085 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 72205-085. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.